As of 2025-05-15, the EV/EBITDA ratio of Fusion Pharmaceuticals Inc (FUSN) is -17.24. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FUSN's latest enterprise value is 1,854.94 mil USD. FUSN's TTM EBITDA according to its financial statements is -107.60 mil USD. Dividing these 2 quantities gives us the above FUSN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.0x - 6.1x | 5.0x |
| Forward P/E multiples | 14.4x - 21.6x | 18.0x |
| Fair Price | (18.47) - (7.92) | (14.84) |
| Upside | -185.7% - -136.8% | -168.8% |
| Date | EV/EBITDA |